Internal Med Medical News about Malignant Pleural Mesothelioma

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans
The Journal of Nuclear Medicine, 09/07/07

Francis, R.J., et al. - Conclusion: Semiquantitative 18F-FDG PET using the volume-based parameter of TGV is feasible in mesothelioma and may predict response to chemotherapy and patient survival after 1 cycle of treatment. Therefore, metabolic imaging has the potential to improve the care of patients receiving chemotherapy for mesothelioma by the early identification of responding patients. This technology may also be useful in the assessment of new systemic treatments for mesothelioma

<< Previous
Application of 99mTc-Pertechnetate Scintigraphy to Microvascular...

Next >>
Very Low Probability Interpretation of V/Q Lung Scans in...

Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature
World Journal of Surgical Oncology, 11/12/09 Relevance Score: 82%

Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09 Relevance Score: 81%

Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis
Pathology International, 10/20/09 Relevance Score: 81%

Second-line treatment for malignant pleural mesothelioma
Cancer Treatment Reviews, 11/05/09 Relevance Score: 80%

Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies
European Journal of Cardio-Thoracic Surgery, 10/14/09 Relevance Score: 80%